Form 4: Aethlon Medical Director Forfeits Shares for Tax

Aethlon Medical Director Nicolas Gikakis forfeited 178 shares of common stock to cover tax withholdings related to restricted stock unit conversion.

Summary

• Nicolas Gikakis, a Director at Aethlon Medical Inc. (AEMD), reported a change in beneficial ownership.
• On March 31, 2026, Gikakis forfeited 178 shares of common stock.
• The forfeiture was to cover tax withholdings associated with the conversion of 268 vested and outstanding restricted stock units into common stock.
• The market price of the issuer's common stock at the time of forfeiture was $2.19 per share.
• Following this transaction, Gikakis beneficially owns 1,464 shares of common stock directly.
• The restricted stock units were part of a grant previously reported in a Form 4 filed on April 25, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative action related to equity compensation rather than a discretionary investment decision or a reflection of company performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that the forfeiture of shares to cover tax withholdings upon the vesting and conversion of restricted stock units is a common and routine event for executives and directors receiving equity compensation. This type of transaction is a standard part of managing equity awards and does not typically reflect a discretionary sale or a change in the insider's view of the company's prospects.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in the director's investment thesis or the company's fundamentals.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary forfeiture of shares by a director to cover tax withholdings upon the conversion of restricted stock units. It does not indicate any change in the company's fundamentals or the director's long-term commitment, thus a 'hold' recommendation is appropriate as it provides no new information to alter an existing investment thesis.

Keywords

AEMD, Aethlon Medical, Form 4, insider transaction, stock forfeiture, director, equity compensation, tax withholding